PDF Summary:The Menopause Manifesto, by Jen Gunter

The Menopause Manifesto offers an in-depth exploration of the biological processes behind menopause and the hormonal changes that occur in a woman's body as she transitions through this natural phase. Jen Gunter delves into menopause's evolutionary history, investigating how it may have offered an advantage in humans and species like orcas.

The author also examines the societal perceptions and misconceptions surrounding menopause, from historical misogyny to modern marketing of treatments. Gunter presents an evidence-based approach to managing menopausal symptoms—from cognitive behavioral therapy for hot flashes to understanding risks and benefits of hormone therapy. With practical advice on nutrition, exercise, and lifestyle choices, this guide aims to help women embrace this stage of life.

(continued)...

• During menopause, hormonal changes can affect libido and sexual well-being in women. Decreased estrogen levels can lead to symptoms like vaginal dryness and discomfort during intercourse. Factors beyond hormones, such as physical changes and emotional factors, can also influence sexual desire. It's important for women experiencing these changes to seek support and explore various treatment options to maintain sexual well-being.
• Genitourinary syndrome of menopause (GSM) encompasses various symptoms affecting the genital and urinary areas due to hormonal changes during menopause. Symptoms include vaginal dryness, discomfort during sex, itching, burning, and an increased risk of urinary infections. Proper management may involve using lubricants, moisturizers, and specific treatments to address these symptoms and improve sexual well-being. It's essential for women experiencing these symptoms to seek medical care and discuss available treatment options with healthcare providers.

Views on menopause and strategies for managing its symptoms are influenced by societal and cultural norms.

The experiences of women during menopause have been detrimentally influenced by patriarchal structures, creating a culture where discussions on the subject are often suppressed.

The experiences of women are often overlooked by healthcare providers and society at large.

Our society, which is patriarchal in nature, often maintains a pervasive silence regarding menopause. Many women find themselves unprepared for the sudden changes their bodies experience, frequently due to a lack of dialogue about menopause with their healthcare providers or within their social circles. Unlike puberty, there is no curriculum in schools preparing girls for menopause, and medical professionals rarely discuss it with their patients until after symptoms are present.

Gunter contends that the lack of adequate education and discussion on this subject is harmful as it results in women lacking a complete comprehension of their physiology, thereby perpetuating the belief that the shift toward menopause is inherently challenging, regardless of the severity of the symptoms. Healthcare providers often minimize the issues raised by women or their requests for medical attention, particularly in the case of those who are overweight, by dismissing these experiences as either normal or trivial. Downplaying menopausal symptoms can lead to significant repercussions.

Menopause is often misunderstood as a series of bodily transformations.

Many women encounter troubling symptoms when they begin the transition into menopause. Misinformation about menopause is often disseminated to the public, despite the presence of reliable sources such as scholarly publications and recommendations from professional bodies. Gunter emphasizes the influence of gender bias in medical research, pointing out that studies on menopause have not adequately represented the wide range of women from different racial and ethnic backgrounds. She also points out that the focus on women's reproductive abilities has often eclipsed other important health concerns, despite the fact that women can live more than thirty percent of their lives after menopause, thereby limiting the scope of available knowledge.

Misunderstandings persist regarding the safety and effectiveness of hormone treatment throughout menopause.

Gunter notes a considerable level of worry regarding the use of estrogen to ease symptoms associated with menopause. Thirty years in the past, there was considerable controversy over the safety of hormone therapy throughout the transition of menopause; however, strong recent evidence has shown that many of the fears about its risks were baseless. Beginning hormone therapies for the transition of menopause can be particularly advantageous if started prior to the age of sixty or within ten years after a woman's final menstrual period.

Gunter ascribes the imbalance to multiple contributing elements. The initial understanding of the WHI findings led to a substantial shift in how the risks and benefits of MHT were viewed, after it was revealed that previous data from the 1980s and 1990s, which indicated a beneficial impact on cardiovascular health, was inaccurate. Initial findings from the Women's Health Initiative, when examined in light of deep-seated gender bias and concerns regarding hormone therapy in the menopausal phase, coupled with the pharmaceutical industry's tendency to disclose only positive research outcomes, led to heightened media scrutiny and a rise in lawsuits claiming carelessness. The same anxieties led numerous scientists to halt their investigations into MHT entirely, which exacerbated the scarcity of information.

Women experiencing intense menopausal symptoms frequently encounter a lack of adequate support and options for alternative treatments.

As the data supporting the safety and effectiveness of MHT evolved, new nonhormonal prescription medications also became available, but many of these interventions are not discussed with women. Insufficient understanding paves the way for media personalities, creators of alternative health products, and pharmaceutical corporations to exploit this gap for financial gain. Gunter confronts the sector that promotes concoctions and items purported to mirror naturally occurring bodily substances, derived from botanicals, or distinctively concocted, offering simplistic remedies lacking empirical support that have occasionally proven to be dangerous.

Investigating the development of terminology related to menopause reveals how our understanding and perspective of this phase of life are reflected and influenced by our linguistic choices.

The language used to describe menopause has evolved, shifting from expressions such as "dodging" and "de-throned queens" to a more medical term, "menopause."

Gunter reminds us that medical views of menopause have evolved over hundreds of years, beginning with ancient writings that simply noted menstruation ended with age, signifying an end to fertility. The earliest documented reference to the sudden intense heat and other signs linked to menopause can be traced back to the sixteenth century. During the 17th and 18th centuries, literary works frequently highlighted the importance of consistent menstrual cycles as a sign of robust health, because a lack of these cycles might suggest the possibility of an inability to conceive or the build-up of detrimental substances in the body. Gunter explains that historical documents from the late 1700s and 1800s frequently attributed various health issues encountered by aging women to menopause.

Previously, educational materials and scholarly articles frequently used negative language to describe menopause, consistently associating it with a decrease related to a woman's reproductive capacity. Women were sometimes described as "de-throned queens" upon the cessation of their reproductive functions. Gunter argues that this type of language reflects a societal tendency to devalue women with advancing age.

Investigating how terms such as "menopause," "transition," "atrophy," "failure," and "bioidentical" shape our understanding of women's health and their physical state.

Gunter posits that the term "menopause" might inherently pose problems. The idea was first introduced in the early 1800s by a physician from France, but it was initially met with skepticism by the medical community. A century on, pharmaceutical companies seized upon and extensively promoted the concept, transforming menopause into an ailment deemed in need of medical treatment by advocating for the use of estrogen tablets to alleviate menopausal symptoms, thus reinforcing the notion that menopause necessitates medical treatment. Jen Gunter advocates for the term "climacteric" as it captures the medical viewpoint that both genders experience aging in specific phases.

Gunter explains that the word "pause" in the context of menopause is misleading, as it implies a brief interruption instead of an enduring transformation. The process of menstruation eventually ceases. Gunter argues that by concentrating solely on the end of menstrual cycles instead of recognizing the entire range of changes during menopause and the subsequent phase of life, a sexist viewpoint is perpetuated that reduces women to their reproductive capabilities. The updated and more accurate terms for what used to be known as "vaginal atrophy" and "premature ovarian failure" are now "genitourinary syndrome of menopause" and "primary ovarian insufficiency," respectively. Jen Gunter suggests updating medical terminology to better reflect the realities of those going through what is presently known as menopause.

Investigating how society and individuals view symptoms related to vasomotor changes.

An analysis of the factors that affect the differing prevalence of vasomotor symptoms among various ethnicities and geographical areas.

Menopause often presents with sudden intense heat waves and episodes of sweating at night, which are widely referred to as night sweats. Approximately four out of every five women undergoing the transition to menopause or who have already transitioned experience varying degrees of symptoms. In her analysis, Gunter notes that women in Asia, particularly in Japan, tend to navigate the menopausal transition more smoothly, with a lower incidence of hot flashes, potentially as a result of various factors such as a diet high in plant-based estrogens, genetic factors, societal acceptance of menopausal symptoms, and a deep-seated reverence for the aging process in women.

The emergence of vasomotor symptoms is shaped by the often-ignored complex interaction of psychological and physiological elements.

Women who keep diaries to track their hot flash episodes and undergo separate assessments of these events frequently display discrepancies in the information they provide. Gunter explains that some individuals might experience sensations similar to hot flushes without any actual increase in body temperature, a phenomenon known as ghost hot flushes. Gunter suggests that the complex origins of sudden warmth sensations and the experience of illusory heat episodes are probably due to a complex interplay involving both the mind and the physiological system.

Exploring how cognitive behavioral therapy and different non-medicinal techniques can manage symptoms associated with the regulation and cooling of body temperature.

Gunter recognizes the concerns of numerous women regarding the neglect of their symptoms during menopause and the apprehensions they hold about the risks linked to Menopausal Hormone Therapy (MHT). She offers a range of non-medicinal approaches, such as cognitive behavioral therapy, known to reduce the severity of hot flashes. CBT emphasizes the connection between mental and physical health, aiming to transform and modify the expectations and perceptions associated with hot flashes to lessen their effects.

Investigating the spectrum of menstrual irregularities and seeking appropriate medical advice.

Menopause often begins with various symptoms such as increased menstrual bleeding, irregular timing of periods, and spotting between cycles.

Gunter points out that changes in menstrual cycles, such as irregular periods or increased flow, may occur as women near menopause, but these symptoms are not experienced by all. Fluctuations in estrogen levels lead to the irregularity of menstrual cycles. Occasionally, the variability in the amount of menstrual bleeding can lead to difficulties, including heavy periods that may saturate clothing and lead to considerable discomfort. Awareness that fluctuations in menstrual patterns are typical and not a cause for concern can offer reassurance to many women.

Bleeding that occurs after what could potentially be the final menstrual period may signal an increased risk of endometrial cancer.

Gunter underscores the importance of seeking medical advice if bleeding occurs after a year without menstruation, as it may indicate the initial phase of endometrial cancer, a condition that is treatable if caught promptly.

Assessing whether there is a need for medical interventions like ultrasound scans, obtaining samples from the lining of the uterus, or performing a dilation and curettage procedure.

Gunter explains that how a woman will be evaluated for abnormal bleeding depends on factors such as age, personal history, medication use, and family history. Post-menopausal bleeding generally requires a medical evaluation, which may include employing ultrasound methods or obtaining a sample from the inner layer of the uterus for analysis. Gunter recommends starting with pharmaceutical interventions for pre-menopausal bleeding and, if these do not produce the expected outcomes, she advises considering diagnostic methods like ultrasound or biopsy.

Challenging the prejudiced belief that a woman's worth is tied to her reproductive capabilities, especially as she approaches menopause.

Adapting to a libido that reacts to external prompts.

Gunter elucidates the multifaceted nature of desire, encompassing numerous dimensions. People engage in sexual activities for a variety of reasons that go beyond just impulsive cravings. Arousal that arises in response to external factors is just as legitimate as the kind that stems from spontaneous, internal interest. Gunter highlights that for many women, the state of being aroused typically comes before the emergence of sexual desire.

We must alter our viewpoint when discussing terms related to disorders of desire, such as HSDD.

Gunter contends that the term for diminished sexual interest, known as HSDD, stems from a flawed understanding of sexual response mechanisms, thereby medicalizing what is often a normal experience. Understanding the complex aspects of desire, which is shaped by a variety of factors, led to the elimination of HSDD as an independent classification. Gunter advises women to disregard terms such as HSDD in the context of evaluating their own sexual interest.

Other Perspectives

• While societal and cultural norms do influence views on menopause, it's also true that individual experiences can vary widely, and some women may not feel as impacted by these norms.
• The assertion that patriarchal structures influence women's experiences during menopause could be countered by noting that awareness and understanding of menopause are increasing, and many societies are working to improve women's health education and resources.
• It could be argued that healthcare providers' understanding of menopause is improving, with more training and resources being dedicated to this area of women's health.
• Menopause is indeed a series of bodily transformations, but it could be argued that understanding and acceptance of these changes are growing, and they are being normalized in many cultures.
• Concerning hormone treatment, some may argue that the risks and benefits of hormone therapy are well-understood by many in the medical community, and decisions about treatment are often made with careful consideration of individual circumstances.
• While some women may lack support and alternative treatment options, there are communities and healthcare systems that provide comprehensive care for menopausal symptoms, and these should not be overlooked.
• The evolution of language around menopause could be seen as a reflection of scientific progress and changing social attitudes rather than solely a response to societal or cultural pressures.
• The term "menopause" itself, while it may have certain connotations, is widely recognized and understood, and changing terminology could potentially lead to confusion without significant educational efforts.
• The prevalence of vasomotor symptoms and their interpretation can be seen as an area where more research is needed, rather than a clear-cut case of societal or cultural misunderstanding.
• Cognitive behavioral therapy and non-medicinal techniques for managing menopausal symptoms may not be universally effective or accessible, and some women may find that medical interventions are more helpful for their individual situations.
• The link between menstrual irregularities and menopause is well-established, but some may argue that not all irregularities should be immediately attributed to menopause, as they could indicate other health issues.
• While post-menopausal bleeding can be a sign of endometrial cancer, it's also true that not all bleeding is indicative of cancer, and other less serious conditions should be considered.
• The belief that a woman's worth is tied to her reproductive capabilities is indeed outdated, but some may argue that this belief is not as prevalent as suggested and that many societies value women for a multitude of reasons beyond reproduction.
• The concept of libido and sexual desire is complex, and while external prompts are valid, some may argue that internal physiological factors play a significant role and should not be discounted.
• The discussion of terms like HSDD could be seen as an evolving part of understanding human sexuality, and while the term may be controversial, it could serve as a starting point for important conversations about sexual health.

An examination of how hormone therapy can evolve, offer benefits, and pose risks during the progression toward menopause.

The initial phase of treatment involving hormones for menopause was characterized by an in-depth examination of its intricate evolution and progress within the medical field.

The earliest approaches to treating menopause involved the use of hormones obtained from the ovaries of animals or the fluid surrounding a fetus in the womb.

The concept of employing hormone therapy to mitigate menopausal symptoms emerged in the late 1800s, despite the fact that estrogen and other hormones were unidentified at that time. Gunter explains that, early on, clinicians experimented with injecting extracts from various organs (such as pig ovaries, amniotic fluid) believed to contain these unknown hormonal signals into animals as a proxy for human biology, even though they did not fully understand what was happening. The initial human trials introduced the first methods aimed at tackling symptoms linked to the menopausal transition. Many approaches were found to be ineffective and, in certain instances, led to considerable negative consequences.

The commencement of menopause hormone therapy coincides with the phase when the body starts producing progesterone.

The identification of estrogens occurred in 1929. The development led to the introduction of treatments involving estrogen, which at first were expensive, unwieldy, and necessitated injections that were painful. Regrettably, Gunter points out that the dominant view in medicine previously linked numerous health issues in women of advanced age to menopause, instead of recognizing these issues as a result of it.

The profound effect of creating hormones synthetically in a laboratory setting.

A significant advancement occurred with the laboratory synthesis of estrogen. This pivotal advancement transformed hormone therapy by shifting from the previous approach of obtaining small amounts of estrogen from animal placentas to a technique that proved to be reliable, secure, and much more economical.

In the 1950s and 1960s, the view of Menopausal Hormone Therapy shifted from being seen as a vital component for maintaining health to an option pursued to improve quality of life and physical attractiveness.

During the 1950s and 1960s, the development of hormone synthesis and the conversion of plant steroids into hormones prompted pharmaceutical companies to begin promoting menopause as a condition newly identified in aging women. Gunter emphasizes the attention on women, pointing out that MHT could not only relieve symptoms but also improve their youthful looks, thus boosting their attractiveness from a male perspective.

Grasping the role of progesterone in preserving the stability of the uterine lining is essential.

Gunter illuminates how progesterone serves as a defense for the uterine lining against estrogen's influence, pointing out that the absence of this defense resulted in a significant increase in cases of endometrial cancer in women who received only estrogen therapy. Synthetic versions of progesterone, known as progestins, were combined with estrogen therapies to regulate menstrual bleeding because authentic progesterone wasn't accessible in a pill format until the 1980s. Regular “periods,” which were really bleeding caused by the cyclical withdrawal of a progestin, also made estrogen therapy more palatable to women as it fit with the misogynistic belief that women should have a menstrual period.

The insights from research by the Women's Health Initiative have enhanced the way hormone therapy is utilized during menopause.

When considering hormone therapy in the menopausal phase, it's crucial to balance its benefits with potential risks, taking into account the individual's age and the time elapsed since menopause began.

Preliminary findings from the Women's Health Initiative research suggested a possible association between Hormone Therapy in menopausal women and an increased likelihood of developing breast cancer. Gunter, however, points out that the WHI study used a specific combination of hormones at levels that are higher than what is commonly recommended today, and that the majority of participants in the research were at a significantly higher risk for certain MHT-related complications, like cardiovascular disease, compared to women who might contemplate it currently. Starting hormone therapy for menopause before the age of 60 or within ten years of the final menstrual period seems to offer the greatest benefits with minimal risk.

An in-depth examination of the risks associated with Menopausal Hormone Therapy, which encompasses an increased risk of breast cancer and a possibility of strokes.

Dr. Gunter emphasizes the importance of understanding that while there are risks linked to hormone therapy during menopause, most of these risks are rare, and many are less common than the risks women often accept during pregnancy. The particular hormone selected and the manner in which it is administered affect the potential hazards linked to hormone treatments. Ingesting estrogen has been associated with a marginal increase in the likelihood of blood clots and strokes; nonetheless, the transdermal application of estradiol appears to carry the lowest risk of thrombosis related to this treatment. The risk of breast cancer can be slightly increased by hormone therapy in the period of menopause, especially when the treatment lacks progestogen.

Evaluating the risks associated with hormone therapy during menopause compared to the risks of pregnancy and childbirth.

Women who take hormone therapy in pill form have an annual occurrence of venous thromboembolism, a severe blood clot condition, at a rate of 8 per 10,000, whereas this danger increases to 40 to 65 per 10,000 in the first twelve weeks after giving birth. Gunter highlights that, even though pregnancy and the postpartum period carry an increased risk of venous thromboembolism (VTE), there is no dialogue suggesting that women should avoid conception due to the potential dangers. We are aware of the risks that women confront when giving birth. An assessment of risks versus benefits indicates a higher chance of developing breast cancer linked to prolonged use of birth control pills and having children after the age of 35, as opposed to undergoing hormone therapy during menopause.

Other Perspectives

• The historical use of animal hormones and amniotic fluid may have been based on the best available science at the time, but it lacked a clear understanding of hormone function and carried significant risks.
• The identification of estrogen in 1929 was a significant milestone, but it also led to the over-prescription of estrogen without adequate understanding of the risks, particularly the risk of endometrial cancer.
• While synthetic hormone production was revolutionary, it also led to mass marketing and the potential for overuse of hormone therapies without fully understanding long-term consequences.
• The shift in Menopausal Hormone Therapy from health maintenance to improving quality of life and attractiveness reflects societal pressures on women to maintain youthfulness, which could be seen as a form of gender bias.
• The role of progesterone is indeed crucial, but the historical delay in its use highlights a gap in medical research and the potential harm to women due to incomplete treatment options.
• The Women's Health Initiative research was groundbreaking, but its initial findings also caused widespread fear and confusion, leading to a significant drop in hormone therapy use, which may have been detrimental to some women's health.
• The recommendation to start hormone therapy before age 60 or within ten years of menopause is based on averages and may not be appropriate for all individuals, who may have unique risk profiles.
• The risks associated with hormone therapy, including breast cancer and strokes, are significant concerns and may be underplayed in the text. The comparison with pregnancy risks does not fully acknowledge the voluntary nature of hormone therapy for menopause versus the often unavoidable risks of pregnancy.
• The assertion that risks of hormone therapy are rare may not fully account for individual variability and the potential for underreporting of adverse effects.
• The method of hormone administration affecting risks is an important consideration, but it may not address all concerns regarding hormone therapy, such as the duration of use and individual health factors.
• The comparison of hormone therapy risks to those of pregnancy and childbirth may not be entirely appropriate, as the contexts and choices surrounding these conditions are quite different.
• The claim that the risk of breast cancer from prolonged birth control pill use or having children after 35 is higher than from menopausal hormone therapy may oversimplify the complex factors that contribute to breast cancer risk.

Nutritional habits, supplement intake, and various approaches to lifestyle are crucial in controlling the manifestations linked to the menopausal transition.

Reducing the intake of products associated with negative health outcomes, especially those that have undergone extensive processing.

The conversation focuses on easily digestible sugars. Foods that contain complex carbohydrates

Gunter underscores the importance of maintaining a nutritious diet during the transition into menopause, although she acknowledges the complexity of nutritional science. Adopting a nutritional regimen that emphasizes the consumption of foods with high nutritional value necessitates a thorough evaluation of commonly consumed items that may be overly processed and deficient in vital nutrients. Gunter recommends a diet that focuses on reducing consumption of overly processed foods and items rich in simple sugars, which have been linked to an increased likelihood of developing heart disease and type 2 diabetes.

Discussions regarding the consumption of fats that are of the saturated type. Ensure your diet includes foods abundant in unsaturated fats.

It's crucial to assess the equilibrium of saturated and unsaturated fats after reducing consumption of highly processed foods and sugars that are quickly broken down and absorbed by the body. Ingesting a diet rich in saturated fats, found in items like red meat and dairy products, can elevate the likelihood of developing heart conditions and increase levels of detrimental cholesterol; thus, it is recommended to limit or eliminate consumption of these foods and opt for alternatives rich in unsaturated fats, such as vegetable oils, fish, and nuts.

Consuming dietary fiber is beneficial as it not only improves digestive health but also lowers cholesterol and decreases bodily inflammation.

Fiber that is soluble stands in contrast to other varieties. Grasping the distinct advantages that insoluble fiber offers for digestive health.

A diet high in fiber can be greatly advantageous for women experiencing menopause. Fiber not only aids in digestion but is also suggested by some studies to reduce estrogen levels, which may provide a shield against cancers associated with hormone-related activities, particularly in breast tissue. It is advised by Dr. Gunter that women should keep track of their daily fiber intake over time to evaluate their consumption and aim for at least 25 grams each day.

Some kinds of dietary fiber act as prebiotics, supporting the beneficial microbes in our gut.

Gunter elucidates that fiber acts as nourishment for gut bacteria, thereby promoting their well-being. Humans cannot digest prebiotics, yet they provide essential nourishment for the beneficial microbes in our gut. Dietary fibers additionally function as prebiotics.

Understanding the efficacy and safety, while also identifying the marketing tactics employed for popular products designed to mitigate menopausal symptoms.

Phytoestrogens possess the ability to mimic or counteract the actions of estrogen within the body.

Gunter argues that it is misleading to assert that hormones are derived from plants. Humans cannot acquire hormones such as estrogen and progesterone by eating plant-based foods. Gunter recommends that although plant-based phytoestrogens share certain characteristics with estrogen, these similarities are significantly constrained. Phytoestrogens possess the ability to either replicate or counteract estrogen's influence, depending on their molecular structure and the specific tissue they interact with in the body. Gunter highlights the difference between estrogens derived from plants and those known as phytoestrogens, noting that the crucial hormones used to ease symptoms of menopause are processed from plant steroids found in soybeans or yams, a process that is not considered "natural."

Differentiating between accurate data and marketing assertions about foods and supplements that contain high levels of phytoestrogens, including soy and red clover.

Inclusion of plant-based estrogens, which are prevalent in Asian cuisine, might offer some protection against hormone-related cancers like those of the breast and uterus, yet ingesting these substances in amounts that surpass those found in a typical diet, whether through dietary means or additional supplementation, appears to confer little additional benefit.

Investigating how the intake of dairy products might influence the incidence of breast cancer, along with the involvement of IGF-1.

The nutritional makeup of milk is multifaceted and includes a diverse range of components. Research has shown that women who drink three glasses of milk each day have an 80% higher likelihood of developing breast cancer. While this connection may appear concerning, Gunter explains that it does not mean that 80% of women will experience breast cancer, and she underscores that consuming dairy products such as cheese and yogurt does not increase this risk. The root reason for this distinction continues to be a mystery. The probability that estrogen present in milk contributes to health problems is negligible because of its low levels and inefficient absorption. Gunter suggests that the association between dairy intake and the incidence of breast cancer could be more accurately attributed to the deliberate genetic selection of dairy cows to boost the output of insulin-like growth factor (IGF-1), a substance associated with breast cancer.

Navigating the realm of supplement safety entails understanding the minimal oversight in the sector of nutritional supplements and identifying trustworthy products and vendors.

This scrutiny challenges the myths about "natural" therapies, thoroughly evaluating the safety and efficacy of commonly utilized herbal remedies, such as black cohosh.

The supplement industry profits from the mistaken assumption that items marketed as "natural" inherently offer greater safety and effectiveness. The widespread occurrence of dangerous plants clearly indicates that natural origins do not guarantee the safety of a substance, as Gunter emphasizes. Many natural compounds undergo chemical modification to ensure they are safe for use. The steroids used in hormone therapy for menopause are typically derived from plants and are often sourced from soybeans or yams through a process of chemical modification. Gunter recommends that women scrutinize the support behind supplements. A significant number of these items have not undergone adequate testing and may present safety risks.

The proliferation of misunderstandings regarding hormones labeled as "bioidentical."

Substances commonly marketed as "bioidentical" are frequently characterized as more natural and, as a result, are claimed to be safer. Gunter underscores the inaccuracy of these beliefs. Our bodies produce distinct hormones, and it's important to emphasize that the compounded variants do not have confirmed safety and dosage standards because they have not undergone the stringent research that is typical for pharmaceutical medications. Investigations into compounded products have uncovered considerable variations in the hormone levels present versus what is indicated on the packaging, as well as unsubstantiated reports of negative reactions. Gunter emphasizes the lack of a mechanism for documenting negative outcomes or issues, which continues to propagate the mistaken assumption that the procedure is risk-free.

Understanding the risks linked to the use of hormone combinations, progesterone cream, DHEA, and pregnenolone is crucial.

Jen Gunter advises against the use of progesterone cream for women experiencing menopause, despite its common promotion. The risk of uterine cancer or precancerous conditions may rise for women who rely solely on creams or patches for hormone therapy during menopause, as progesterone does not absorb effectively through the skin. It is frequently recommended to use DHEA as a dietary supplement to mitigate the symptoms associated with menopause. Gunter underscores that claims of improving hormonal equilibrium or boosting bone density and libido lack scientific substantiation. The FDA has sanctioned the use of a prescription vaginal DHEA that appears to be safe and beneficial for those suffering from symptoms linked to the condition known as Genitourinary Syndrome of Menopause. Pregnenolone, yet another hormone that acts as a precursor in the conversion process, is suggested for women experiencing menopause, although there is no substantial proof supporting its efficacy.

Other Perspectives

• While reducing processed foods and simple sugars is generally recommended, some individuals may find that certain processed foods can fit into a balanced diet without negative health impacts, especially if they are fortified with essential nutrients.
• The balance of saturated and unsaturated fats is important, but recent research suggests that the type of saturated fat and the overall dietary context matters, and not all saturated fats have the same health effects.
• High fiber intake is beneficial, but some individuals with certain digestive conditions, such as irritable bowel syndrome (IBS), may need to modify their fiber intake to manage symptoms.
• The role of phytoestrogens in the diet is complex, and while they can mimic or counteract estrogen, their effects can vary widely among individuals, and more research is needed to fully understand their impact on menopausal symptoms and long-term health.
• The relationship between dairy intake and breast cancer risk is not fully understood, and some studies suggest that dairy may have a neutral or even protective effect against certain types of cancer.
• The supplement industry does have some oversight, such as regulations by the FDA in the United States, although it is less stringent than the pharmaceutical industry. Some supplements may have evidence supporting their safety and efficacy.
• The term "bioidentical" is often misunderstood, but some bioidentical hormones are FDA-approved and have been shown to be effective and safe when used appropriately.
• While there are risks associated with hormone combinations, progesterone cream, DHEA, and pregnenolone, some individuals may benefit from these treatments under the guidance of a healthcare provider, and there is research supporting the use of some of these therapies for specific indications.